跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,268 条关于
“Accent Prime”
全部
7,268
临床试验
5,373
药物
165
机构
41
资讯
1,689
去年
Nature Study Validates Non-Invasive Fat Reduction Technology for Abdominal Obesity Treatment
去年
Amplia Therapeutics Resumes ACCENT Trial Enrollment for Pancreatic Cancer
去年
Narmafotinib Combination Shows Superior Response in Pancreatic Cancer ACCENT Trial
去年
Accent Therapeutics' ATX-559, a First-in-Class DHX9 Inhibitor, Receives FDA IND Clearance for Solid Tumor Trial
9个月前
Prime Medicine Reports First-in-Human Prime Editing Success for Chronic Granulomatous Disease in NEJM
去年
Prime Medicine Reports Breakthrough Clinical Data for First Prime Editing Therapy in Chronic Granulomatous Disease
去年
Accent Therapeutics Doses First Patient in Phase 1/2 Trial of DHX9 Inhibitor ATX-559
去年
Accent Therapeutics Initiates Phase I/II Trial of Novel KIF18A Inhibitor for Advanced Solid Tumors
11个月前
Boehringer Ingelheim Acquires First-in-Class Oncology Asset from Accent Therapeutics Targeting High ISG Expression Tumors
去年
Accent Therapeutics to Showcase Novel Cancer Therapeutics ATX-559 and ATX-295 at AACR 2025
第 1 页,共 169 页
上一页
下一页